尼日利亚随机对照试验比较即时与标准HIV病毒载量监测的临床结局
在尼日利亚城乡两所医院开展随机对照试验,268例标准监测与273例即时监测患者按1:1随机分组。12个月病毒抑制率在意向治疗分析中两组无显著差异(即时59.3% vs 标准52.2%,P=0.096),符合方案分析中即时组较高(77.1% vs 65.9%,P=0.012);即时监测改善保留率与病毒载量记录,且被多数患者和医务人员偏好。
要点
- 意向治疗分析中12个月病毒抑制率即时组59.3% vs 标准组52.2%,无显著差异(P=0.096)。
- 符合方案分析中病毒抑制率即时组77.1% vs 标准组65.9%,P=0.012。
- 90.2%患者和100%医务人员偏好即时监测,认为其促进患者照护。
核心结论
- 即时病毒载量监测未改善有结果者的12个月病毒抑制,但改善了保留率和病毒载量记录,且被多数患者和医务人员偏好。
研究设计与样本
- 在尼日利亚一所城市医院和一所农村医院实施的随机对照试验,268例标准监测与273例即时监测患者按1:1随机分组。
主要发现
- 12个月病毒载量<1000拷贝/mL的病毒抑制率在意向治疗分析中即时组59.3%(162/273)vs 标准组52.2%(140/268),P=0.096。
- 符合方案分析中病毒抑制率即时组77.1%(158/205)vs 标准组65.9%(137/208),P=0.012。
- 保留率在意向治疗分析中无显著差异,符合方案分析中即时组85.9% vs 标准组76.9%,P=0.02。
- 即时组病毒抑制增加归因于保留率改善和病毒载量结果记录改善。
- 90.2%(147/163)患者偏好即时监测,100%(15/15)医务人员认为即时监测促进患者照护。
关键数值与推荐
- 病毒抑制定义为病毒载量<1000拷贝/mL。
- 即时监测使用Cepheid Xpert检测,标准监测使用Roche COBAS v2.0检测。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者指出需进一步研究以确定最佳即时监测实施条件和优化患者照护的方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Point-of-care (POC) viral load (VL) tests provide results within hours, enabling same-day treatment interventions. We assessed treatment outcomes with POC vs standard-of-care (SOC) VL monitoring. METHODS: We implemented a randomized controlled trial at an urban and rural hospital in Nigeria. Participants initiating antiretroviral therapy (ART) were randomized 1:1 for monitoring via the POC Cepheid Xpert or SOC Roche COBAS (v2.0) HIV-1 VL assays. Viral suppression (VS) and retention in care at 12 months were compared via intention-to-treat (ITT) and per-protocol (PP) analyses. Post-trial surveys for POC patients and healthcare workers (HCWs) evaluated acceptability. RESULTS: During April 2018-October 2019, 268 SOC and 273 POC patients enrolled in the trial. Viral suppression at <1000 copies/mL at 12 months was 59.3% (162/273) for POC and 52.2% (140/268) for SOC (P = .096) in ITT analysis and 77.1% (158/205) for POC and 65.9% (137/208) for SOC (P = .012) in PP analysis. Retention was not significantly different in ITT analysis but was 85.9% for POC and 76.9% for SOC (P = .02) in PP analysis. The increased VS in the POC arm was attributable to improved retention and documentation of VL results. POC monitoring was preferred over SOC by 90.2% (147/163) of patients and 100% (15/15) of HCWs thought it facilitated patient care. CONCLUSIONS: POC VL monitoring did not improve 12-month VS among those with results but did improve retention and VS documentation and was preferred by most patients and HCWs. Further research can inform best POC implementation conditions and approaches to optimize patient care. CLINICAL TRIALS REGISTRATION: NCT03533868.
引用
- Chang C, Agbaji O, Mitruka K, et al. Clinical Outcomes in a Randomized Controlled Trial Comparing Point-of-Care With Standard Human Immunodeficiency Virus (HIV) Viral Load Monitoring in Nigeria. Clin Infect Dis. 2023. PMID: 35867672. doi:10.1093/cid/ciac605
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。